Oakbrook Investments LLC increased its position in Agilent Technologies Inc (NYSE:A) by 17.3% during the third quarter, HoldingsChannel reports. The institutional investor owned 25,810 shares of the medical research company’s stock after purchasing an additional 3,800 shares during the period. Oakbrook Investments LLC’s holdings in Agilent Technologies were worth $1,821,000 at the end of the most recent reporting period.
Other large investors have also recently bought and sold shares of the company. Quantitative Systematic Strategies LLC lifted its position in shares of Agilent Technologies by 247.6% in the second quarter. Quantitative Systematic Strategies LLC now owns 23,818 shares of the medical research company’s stock worth $1,473,000 after buying an additional 16,966 shares in the last quarter. Paloma Partners Management Co lifted its position in shares of Agilent Technologies by 119.6% in the second quarter. Paloma Partners Management Co now owns 26,924 shares of the medical research company’s stock worth $1,665,000 after buying an additional 14,661 shares in the last quarter. Point72 Asset Management L.P. purchased a new stake in shares of Agilent Technologies in the second quarter worth about $6,308,000. Harvey Investment Co. LLC purchased a new stake in shares of Agilent Technologies in the second quarter worth about $5,742,000. Finally, MAI Capital Management bought a new stake in Agilent Technologies during the second quarter worth approximately $394,000.
Several brokerages have weighed in on A. Zacks Investment Research cut Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Tuesday. Morgan Stanley boosted their price objective on Agilent Technologies from $84.00 to $86.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 10th. Goldman Sachs Group reissued a “buy” rating and set a $82.00 price objective (up from $77.00) on shares of Agilent Technologies in a research note on Tuesday, September 18th. ValuEngine raised Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Thursday, September 13th. Finally, Deutsche Bank boosted their price objective on Agilent Technologies from $77.00 to $80.00 and gave the stock a “buy” rating in a research note on Wednesday, August 15th. One research analyst has rated the stock with a hold rating and nine have issued a buy rating to the company. Agilent Technologies has an average rating of “Buy” and an average price target of $77.44.
Shares of NYSE A opened at $64.47 on Friday. The company has a current ratio of 3.62, a quick ratio of 3.00 and a debt-to-equity ratio of 0.39. Agilent Technologies Inc has a 1-year low of $60.42 and a 1-year high of $75.00. The company has a market cap of $20.96 billion, a price-to-earnings ratio of 27.32, a P/E/G ratio of 2.25 and a beta of 1.32.
Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Tuesday, August 14th. The medical research company reported $0.67 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.63 by $0.04. Agilent Technologies had a return on equity of 18.61% and a net margin of 6.20%. The company had revenue of $1.20 billion for the quarter, compared to analysts’ expectations of $1.20 billion. During the same period in the previous year, the firm posted $0.59 earnings per share. The firm’s revenue for the quarter was up 8.0% on a year-over-year basis. As a group, analysts predict that Agilent Technologies Inc will post 2.71 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 24th. Stockholders of record on Tuesday, October 2nd will be paid a dividend of $0.149 per share. The ex-dividend date is Monday, October 1st. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.92%. Agilent Technologies’s dividend payout ratio is 25.42%.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.
Featured Article: Investing strategies using the yield curve
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.